Latest News

Wondering whether UiPath shares offer value at today's price, or if the market is pricing in too much hope already? This article walks through what the numbers are actually saying about the stock. UiPath's recent share price has moved to US$12.59, with returns of 14.9% decline over 7 days, 20.7% decline over 30 days, 20.7% decline year to date, 11.5% decline over 1 year and 25.5% decline over 3 years. Recent coverage has focused on UiPath as an AI and automation player in a competitive...

There's been a notable change in appetite for Coveo Solutions Inc. ( TSE:CVO ) shares in the week since its...

RWE (XTRA:RWE) has just approved a large scale 400 MW battery storage project in Lingen, designed to supply balancing energy and support grid stability as part of its broader energy transition plans. See our latest analysis for RWE. The Lingen battery decision comes at a time when momentum in RWE’s shares has been strong, with a 30 day share price return of 14.09% and a 90 day share price return of 24.78%. Over the longer run, total shareholder return sits at 85.07% over one year and 68.79%...

Government intervention and cancelled asset sale put Eutelsat in focus Eutelsat Communications (ENXTPA:ETL) is back on investors’ radar after the French government blocked the sale of its ground antennas, highlighting security concerns and the group’s role as a European rival to Starlink. See our latest analysis for Eutelsat Communications. The cancelled asset sale and government intervention come after a volatile stretch for Eutelsat, with a 30 day share price return of 27.94% but a 90 day...

Biogen's litifilimab (BIIB059) has received FDA Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus. The designation is based on Phase 2 trial results that suggest litifilimab may address an unmet medical need in CLE. This status may allow for expedited development and review of the therapy by the FDA. For investors watching NasdaqGS:BIIB, the new designation comes with the stock trading at $179.89 and a 25.0% return over the past year, while longer term...

If you are wondering whether Elevance Health's current share price offers good value or not, it helps to look past the headlines and focus on what the numbers are saying. The stock last closed at US$345.74, with returns of a 6.8% decline over 7 days, a 2.4% decline over 30 days, a 2.4% decline year to date, and a 10.9% decline over 1 year, while the 5 year return sits at 27.2%. Recent news around Elevance Health has centered on broader healthcare policy discussions and insurer sentiment,...

Pfizer agreed to acquire Metsera for $10 billion, aiming to expand into obesity and weight loss drugs. The company is reshaping its R&D focus toward metabolic disease, oncology and immunology. Pfizer signed a licensing deal with Novavax for Matrix M adjuvant technology to support vaccine development. Pfizer (NYSE:PFE), trading around $26.44, is trying to reposition itself after a difficult multi year share price period, with a reported 28.1% decline over 3 years and 2.8% decline over 5...

What Samsung Electronics’ recent performance means for investors Samsung Electronics (KOSE:A005930) has been back on many watchlists after a strong share price move, with the stock up around 34% over the past month and roughly 49% in the past 3 months. Those short term returns sit on top of a much longer run, with the 1 year total return above 200%. For investors, that kind of performance often raises a straightforward question: whether the current price still lines up with the company’s...

If you are wondering whether Planet Fitness shares offer good value at current levels, this article walks through what the numbers actually say about the stock. The share price closed at US$91.04, with returns of a 3.6% decline over the last 7 days, 17.0% decline over 30 days, 17.0% decline year to date, 15.8% decline over 1 year, 11.1% gain over 3 years and 17.0% gain over 5 years, which gives a mixed picture for anyone thinking about long term performance. Recent news flow around Planet...

Mondelez International (MDLZ) has put leadership in sharper focus, asking long-time Chief Financial Officer Luca Zaramella to also serve as Chief Operating Officer, centralizing financial and commercial decision making under one experienced executive. See our latest analysis for Mondelez International. The leadership reshuffle comes as the share price trades at US$58.47, with a 1 month share price return of 8.98% and a 1 year total shareholder return of 4.01%, while the 3 year total...

On January 29, 2026, Keysight Technologies and Point2 Technology announced a collaboration to validate Point2’s e-Tube interconnects aimed at easing AI and machine learning data center bottlenecks using Keysight’s high-speed digital test platforms. The partnership highlights how test and measurement expertise can become a critical enabler for hyperscalers seeking lower-power, longer-reach alternatives to traditional copper and optics in xPU clusters. With this AI-focused collaboration in...

Why Perella Weinberg Partners (PWP) is on investors’ radar Perella Weinberg Partners (PWP) has drawn attention after a month return of about 27% and a past 3 months gain of roughly 21%, prompting investors to reassess its advisory driven business and recent financial metrics. See our latest analysis for Perella Weinberg Partners. The recent 30 day share price return of 27.1% and 90 day gain of 20.6% at a latest share price of $22.31 suggest building momentum. This comes alongside a mixed...

If you are wondering whether Viper Energy at around US$42.34 still offers value, you are not alone, especially with energy stocks often moving in sharp cycles. Over the last week the share price return was 6.8%, with a 9.2% return over the past month, although the return over the last year was a 4.3% decline. Recent news flow around Viper Energy has focused on its role as a mineral and royalty interest owner in the Permian Basin and how its asset base ties into broader US oil and gas...

Investors in Meta Platforms, Inc. ( NASDAQ:META ) had a good week, as its shares rose 8.8% to close at US$717 following...

Solos Technology has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) over smart glasses technology. The complaint targets Meta's Ray-Ban smart glasses and claims infringement of multiple Solos patents tied to audio, sensing, and real-time user interaction. Solos is seeking significant damages and an injunction that could affect Meta's wearables business and broader platform plans. The lawsuit also cites alleged internal awareness at Meta of Solos' patents before...

As you might know, Axos Financial, Inc. ( NYSE:AX ) just kicked off its latest quarterly results with some very strong...

Bankwell Financial Group, Inc. ( NASDAQ:BWFG ) last week reported its latest annual results, which makes it a good time...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Citizens...

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...

The yearly results for GCC, S.A.B. de C.V. ( BMV:GCC ) were released last week, making it a good time to revisit its...

Arca Continental, S.A.B. de C.V.'s ( BMV:AC ) price-to-earnings (or "P/E") ratio of 16.5x might make it look like a...

Sound Financial Bancorp, Inc.'s ( NASDAQ:SFBC ) dividend will be increasing from last year's payment of the same period...

The board of Provident Financial Services, Inc. ( NYSE:PFS ) has announced that it will pay a dividend on the 27th of...

We wouldn't blame Americas Gold and Silver Corporation ( TSE:USA ) shareholders if they were a little worried about the...